KCNJ5 and breast cancer: Since the predominant GIRK heterotetramers seem to be GIRK1/2 (brain) and GIRK1/4 (cardiac) [reviewed in [11] &[12]], we concentrated on GIRK1, GIRK 2, and GIRK4 expression in these breast cancer cells.